A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
Seagen Inc.
Seagen Inc.
National Institutes of Health Clinical Center (CC)
AstraZeneca
University of Pittsburgh
Zymeworks BC Inc.
National Cancer Institute (NCI)
Travera Inc
7 Hills Pharma, LLC
Nammi Therapeutics Inc
National Cancer Institute (NCI)
OncoC4, Inc.
Regeneron Pharmaceuticals
University Hospital, Angers
Sotio Biotech Inc.
National Institutes of Health Clinical Center (CC)
Aptamer Sciences, Inc.
Hoffmann-La Roche
3D Medicines
National Cancer Institute (NCI)
Tel-Aviv Sourasky Medical Center
Exelixis
Mayo Clinic
Mayo Clinic
Ohio State University
M.D. Anderson Cancer Center
ViroMissile, Inc.
Essen Biotech
OHSU Knight Cancer Institute
DualityBio Inc.
MacroGenics
Hefei TG ImmunoPharma Co., Ltd.
City of Hope Medical Center
xCures
Grey Wolf Therapeutics
Jiangsu Simcere Pharmaceutical Co., Ltd.
Zhejiang University
Wondercel Biotech (ShenZhen)
ImmunityBio, Inc.
Indaptus Therapeutics, Inc
Ocellaris Pharma, Inc.
Hoffmann-La Roche
Dysplasia Diagnostics Limited
Elephas
Mayo Clinic
Incyte Corporation
Degron Therapeutics Co.
Mayo Clinic
GV20 Therapeutics
NeoTX Therapeutics Ltd.
West China Hospital